
Sign up to save your podcasts
Or


The USPSTF recommends the use of preexposure prophylaxis (PrEP) with effective antiretroviral therapy in patients at high risk for HIV acquisition. Who is at high risk?
For more information on HIV screening and many other topics in medicine, please visit Univadis.com.
By Alissa ScottThe USPSTF recommends the use of preexposure prophylaxis (PrEP) with effective antiretroviral therapy in patients at high risk for HIV acquisition. Who is at high risk?
For more information on HIV screening and many other topics in medicine, please visit Univadis.com.